Advancing Life Science and Biomedical Manufacturing

Facing ongoing competitive pressures and market growth demands, life science and biomedical OEMs must constantly deliver new advancements in technology, processes, workflows, and production.

But in addition to pursuing improvements that focus on expanding success, OEMs must also ensure against the in-use failures of their advanced equipment.

In the case of advanced instruments utilized in research, scientific, medical, and other critical applications, neglecting improvements and safeguards in one seemingly minor component — in-process linear motion systems — can generate consequences ranging from inconvenient to catastrophic.

A new white paper details how next-generation linear motion systems can be specified, designed, installed, and maintained to advance life science and biomedical capital equipment manufacturing — and ensure against failures of any consequence.

This new white paper highlights how next-generation linear motion systems can be specified, designed, installed, and maintained to both advance life science and biomedical capital equipment manufacturing — and ensure against failures of any consequence.

Download the technical brief